Evidence map›Paper›PMID 41366864›Full record

ArticleJournal of proteome research2026

High-Mannose

Francis M Wanyama, Obinna Umeh, Karina Biskup, Rudolf Tauber, Alfred Mokomba, Catherine Nyongesa, Véronique Blanchard

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of proteome research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Francis M WanyamaInstitute of Diagnostic Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health. Post: Augustenburger Platz 1, Berlin D-13353, Germany.
Obinna UmehInstitute of Diagnostic Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health. Post: Augustenburger Platz 1, Berlin D-13353, Germany.
Karina BiskupDepartment of Human Medicine, Medical School Berlin, Rüdesheimer Straße 50, Berlin 14197 Germany.
Rudolf TauberInstitute of Diagnostic Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health. Post: Augustenburger Platz 1, Berlin D-13353, Germany.ORCID 0000-0002-0687-3940
Alfred MokombaDepartment of Obstetrics and Gynecology, Kenyatta National Hospital, Ngong Road, P.O. Box 20723, Nairobi 00202, Kenya.
Catherine NyongesaCancer Treatment Centre, Kenyatta National Hospital, Ngong Road, P.O. Box 20723, Nairobi 00202, Kenya.
Véronique BlanchardInstitute of Diagnostic Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health. Post: Augustenburger Platz 1, Berlin D-13353, Germany.ORCID 0000-0002-5980-6450

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epithelial ovarian cancer (EOC) remains the most lethal form of cancer despite improvements in surgical techniques and therapeutic interventions over recent decades. The high mortality rate is largely associated with a lack of sensitive and specific early diagnostic biomarkers to allow timely intervention. Hence, the identification and validation of novel noninvasive biomarkers for primary diagnosis and for disease monitoring is of high importance. Malignant transformations of

Indexed as

Biomarkers, TumorCarcinoma, Ovarian EpithelialMannoseOvarian NeoplasmsPolysaccharidesAdultAgedFemaleGlycosylationHumansMiddle AgedPilot ProjectsBiomarkers, TumorMannosePolysaccharidesAfrican ethnicitybenign ovarian diseasecancer biomarkerschemotherapy responseMALDI-TOF mass spectrometryN-glycansovarian cancerpermethylation

Identifiers

PMID41366864
PMCPMC12772126

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.